We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,559 results
  1. Fulminant Myocarditis

    This book provides readers recent advances on basic research and clinical management of fulminant myocarditis. First chapters introduce aetiology,...
    Dao Wen Wang
    Book 2022
  2. Fulminant Myocarditis Temporally Associated with COVID-19 Vaccination

    Purpose of Review

    Coronavirus disease-2019 (COVID-19) vaccines have been related to rare cases of acute myocarditis, occurring between 1 in 10,000 and...

    Enrico Ammirati, Nicolina Conti, ... Alberto Cereda in Current Cardiology Reports
    Article 07 February 2024
  3. Fulminant myocarditis with adult-onset Still’s disease: case-based review

    Myocarditis has been reported as a life-threatening complication of adult-onset Still’s disease (AOSD), but fulminant myocarditis with AOSD is very...

    Ryohei Ono, Togo Iwahana, ... Yoshio Kobayashi in Clinical Rheumatology
    Article 01 June 2023
  4. Clinical analysis of temporary pacemaker implantation in 6 children with fulminant myocarditis

    Background

    There is little literature on the use of temporary pacemakers in children with fulminant myocarditis. Therefore, we summarized the use of...

    Min Zhang, **aofang Cai, Yong Zhang in Journal of Cardiothoracic Surgery
    Article Open access 22 May 2024
  5. Anakinra in pediatric acute fulminant myocarditis

    Background

    Acute fulminant myocarditis in children is associated with elevated mortality and morbidity with few advances in its medical management....

    Louise Maunier, Ramy Charbel, ... Joy Zogby in Annals of Intensive Care
    Article Open access 26 August 2022
  6. Development and Validation of a Prediction Model on Adult Emergency Department Patients for Early Identification of Fulminant Myocarditis

    Objective

    It is difficult to predict fulminant myocarditis at an early stage in the emergency department. The objective of this study was to construct...

    Min Jiang, Jian Ke, ... Yuan-yuan Li in Current Medical Science
    Article 14 July 2023
  7. Fulminant myocarditis during postoperative adjuvant chemotherapy for lung cancer with atezolizumab: a case report

    Background

    Postoperative adjuvant systemic therapy with atezolizumab for lung cancer has been reported to be effective. Although myocarditis is a rare...

    Takuya Tokunaga, Masaya Aoki, ... Kazuhiro Ueda in Journal of Medical Case Reports
    Article Open access 16 March 2024
  8. A Novel Marker for Predicting Fulminant Myocarditis: Systemic Immune–Inflammation Index

    In myocarditis, the search for effective and appropriate prognostic biomarkers can help clinicians identify high-risk patients in a timely manner and...

    Raziye Merve Yaradilmiş, Muhammed Mustafa Güneylioğlu, ... Nilden Tuygun in Pediatric Cardiology
    Article 19 August 2022
  9. Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory support

    Background

    Fulminant myocarditis is a rare and severe disease whose definite and etiological diagnoses rely on pathological examination. Albeit,...

    Yann Marquet, Guillaume Hékimian, ... Marc Pineton de Chambrun in Annals of Intensive Care
    Article Open access 31 August 2023
  10. A case of destination therapy for post-fulminant myocarditis with myelodysplastic syndrome

    We encountered a 64-year-old woman who experienced fulminant myocarditis and underwent treatment with veno-arterial extracorporeal membrane...

    Makiko Nakamura, Teruhiko Imamura, ... Koichiro Kinugawa in Journal of Artificial Organs
    Article 11 June 2024
  11. Atrial-His bundle pacing in fulminant myocarditis with ventricular arrhythmia: a case report

    Background

    Fulminant myocarditis is a clinical syndrome associated with threatening dysrhythmia which temporary pacemaker can be used for life-saving...

    Limeng Jiang, Liangguo Wang, ... Lan Su in BMC Cardiovascular Disorders
    Article Open access 22 November 2022
  12. An autopsy case of lung adenocarcinoma with immune checkpoint inhibitor-induced pneumonia and fulminant myocarditis following pembrolizumab administration: a case report

    Immune checkpoint inhibitors (ICIs) are the current standard of care for non-small-cell lung cancer (NSCLC). Myocarditis is a rare but serious...

    Takahiko Hashimoto, Kosuke Takahashi, ... Toru Hara in International Cancer Conference Journal
    Article 30 March 2024
  13. Central extracorporeal membrane oxygenation with left-ventricular vent for fulminant myocarditis: a retrospective study

    Purpose

    Fulminant myocarditis presents as acute severe heart failure and requires mechanical cardiocirculatory support. Left-ventricular (LV)...

    Masaki Komatsu, Kazuki Naito, ... Tatsuichiro Seto in Journal of Artificial Organs
    Article 08 November 2022
  14. Fenestrated Fontan-like circulation under durable left-ventricular assist device support in fulminant myocarditis

    Fulminant myocarditis is a fatal development from profound biventricular heart failure and often requires both right- and left-ventricular assistance...

    Chiho Tokunaga, Atsushi Iguchi, ... Akihiro Yoshitake in Journal of Artificial Organs
    Article 24 August 2022
  15. Analysis of Cytokine Profiles in Pediatric Myocarditis Multicenter Study

    Acute myocarditis (AM) is an inflammatory disease of the heart muscle that can progress to fulminant myocarditis (FM), a severe and life-threatening...

    Yoji Nomura, Takanori Suzuki, ... Kazushi Yasuda in Pediatric Cardiology
    Article 13 March 2024
  16. Trans-subclavian approach for Impella CP implantation using the chimney graft in a pediatric patient with fulminant myocarditis during extracorporeal support

    Impella is a device effective for the treatment of cardiogenic shock. However, among small children, its application has limitations due to left...

    Masaki Hirose, Hidekazu Ishida, ... Shigeru Miyagawa in Journal of Artificial Organs
    Article 12 October 2022
  17. Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis

    Background

    Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly develo** acute heart failure.

    Case presentation ...
    Takayuki Hori, Mitsuru Iida, ... Tomoki Shimokawa in Journal of Cardiothoracic Surgery
    Article Open access 12 April 2022
  18. Impact of renal complications on outcome in adult patients with acute fulminant myocarditis receiving venoarterial extracorporeal membrane oxygenation: an analysis of nationwide CSECLS database in China

    Background

    Limited data are available on renal complications in patients with acute fulminant myocarditis (AFM) receiving venoarterial extracorporeal...

    Tong Hao, Lei Chen, ... Haibo Qiu in Annals of Intensive Care
    Article Open access 27 September 2023
  19. The diagnosis and treatment of pediatric clinical myocarditis in China: a multicenter retrospective study

    This study aims to examine the clinical characteristics and outcomes of clinical myocarditis in pediatric patients in China. This is a multicenter...

    **aoou Li, Hu Tuo, ... Junbao Du in European Journal of Pediatrics
    Article 13 December 2023
  20. Enhanced recovery from fulminant myocarditis by treatment with the combined use of the Impella left ventricular assist device with extracorporeal membrane oxygenation: a case series

    Background

    We experienced two adult cases of fulminant myocarditis with severe cardiogenic shock where Impella left ventricular assist device [left...

    Hideyuki Nandate, Tasuku Nishihara, ... Toshihiro Yorozuya in JA Clinical Reports
    Article Open access 27 February 2022
Did you find what you were looking for? Share feedback.